A modulator of diverse GPCRs
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Research Area

SCH 202676 (hydrobromide)

Item No. 16945

Technical Information
Formal Name
N-(2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene)-methanamine, monohydrobromide
CAS Number
265980-25-4
Molecular Formula
C15H13N3S • HBr
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 5 mg/mlDMSO: 10 mg/mlDMSO:PBS(pH7.2) (1:1): 0.5 mg/ml
λmax
205, 275 nm
SMILES
C/N=C1SN(C2=CC=CC=C2)C(C3=CC=CC=C3)=N\1.Br
InChi Code
InChI=1S/C15H13N3S.BrH/c1-16-15-17-14(12-8-4-2-5-9-12)18(19-15)13-10-6-3-7-11-13;/h2-11H,1H3;1H/b16-15-;
InChi Key
YJYGOWVFDGULLL-YFKNTREVSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    SCH 202676 is a reversible inhibitor of both agonist and antagonist binding to diverse G protein-coupled receptors (GPCRs).1 It blocks the binding of radiolabeled ligands to human opioid, adrenergic, muscarinic, dopaminergic, adenosine, and purinergic receptors.1,2,3 It displays IC50 values of 0.1 to 1.8 µM for modulating ligand binding.1,2 SCH 202676 may modulate GPCRs via thiol modification.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fawzi, A.B., Macdonald, D., Benbow, L.L., et alSCH-202676: An allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors. Mol. Pharmacol. 59(1), 30-37 (2001).

    2. Gao, Z.G., Kim, S.K., Ijzerman, A.P., et alAllosteric modulation of the adenosine family of receptors. Mini Rev. Med. Chem. 5(6), 545-553 (2005).

    3. Lanzafame, A., and Christopoulos, A. Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 308(3), 830-837 (2004).

    4. Lewandowicz, A.M., Vepsäläinen, J., and Laitinen, J.T. The 'allosteric modulator' SCH-202676 disrupts G protein-coupled receptor function via sulphydryl-sensitive mechanisms. Br. J. Pharmacol. 147(4), 422-429 (2006).